UMass Chan Signs Agreement with Red Cell to Develop AI Products
Becker's Hospital Review
|
Contributed by: Kate Gamble
Summary
Chan Medical School and Red Cell Partners work together to advance AI technologies for healthcare. Their two-year partnership will involve selecting and testing AI products from Red Cell's portfolio using clinical data to validate safety and effectiveness. UMass Chan will also join Red Cell’s program to streamline the deployment of viable AI tools in the sector. Dr. Adrian Zai emphasized the initiative's aim to attract AI companies and establish industry guidelines, while UMass Chan will be compensated for data access and services.
